America Stem Cell, Inc. Company Profile
America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of stem cell enabling technologies/products to transform clinical outcomes for patients undergoing stem cell transplantation. The key stem cell enabling platform technologies/compounds (ASC-101 and ASC-201) designed to improve the homing and engraftment of stem cells to target organs and increase their therapeutic potential for patients in need of stem cell transplantation. Additionally, these platforms have the potential to enhance stem cell treatment of inflammation from chemotherapy/radiation, solid tumors, autoimmune diseases, and ischemic diseases including myocardial infarction and stroke. America Stem Cell has strategic partnerships with medical research institutions including The University of Texas M.D. Anderson Cancer Center, Oklahoma Medical Research Foundation, National Institute of Health, Fred Hutchinson Cancer Center, University of California San Diego, the Sanford-Burnham Institute, Indiana University, Juvenile Diabetes Research Foundation, as well as corporate partnerships. For additional information, please contact Lynnet Koh at 210-410-6427 or view http://www.americastemcell.com.
News Articles
Stem cell researchers discuss latest discoveries at the New York Stem Cell Foundation Conference
(New York Stem Cell Foundation) Leaders in translational stem cell research from across the country and around the world will present findings on how advances in stem cell science lead to better treat...
Stem Cell Therapeutics (TSX VENTURE: SSS) Merger with Trillium Therapeutics and 1 for 10 reverse
Canadian stem cell research strives for survival Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a life sciences company developing stem cell-related technologies, executed a Letter of Agreement wit...
Scientists discuss stem cell discoveries at New York Stem Cell Foundation Conference
(New York Stem Cell Foundation) For the second day, The New York Stem Cell Foundation Seventh Annual Translational Stem Cell Research Conference hosts the worlds most preeminent stem cell scientists...
Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning
In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...
World Stem Cells, LLC. facilitates Stem Cell Treatments In Cancun at World Stem Cells Clinic
Lutz, Florida (PRWEB) February 05, 2013 World Stem Cells, LLC. contract laboratory and clinic World Stem Cells Clinic a new adult stem cell laboratory being built in Cancun, Mexico to support Stem...
Do Stem Cell Claims in Aesthetic Surgery Hold Up?
New York, NY (PRWEB) April 15, 2013 Are âstem cell faceliftsâ and âstem cell breast augmentationâ better than traditional procedures? Although stem cell therapy may be promising...
TORONTO, ONTARIO -- (Marketwired) -- 04/17/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced the e...
Arlington, VA (PRWEB) January 15, 2013 The growth in the stem cell market has enticed new suppliers to enter this space, and they have been successful in capturing a (small) share of the stem cell...
Drugs and Medications
Skinovage nanocell age protecting [Babor Cosmetics America, Corp.]
Antimicrobial [Safetec of America]
Antimicrobial
A.b.h.c. instant hand sanitizer citrus scent [Safetec of America, Inc.]
A.B.H.C. INSTANT HAND SANITIZER
Hydrocortisone [Safetec of America, Inc.]
Safetec First Aid 1% Hydrocortisone Cream
Analgesic [Safetec of America, Inc.]
Safetec of America, Inc. PAIN SPRAY
PubMed Articles
New stem cell meeting on the Baltic Sea is launched.
Cell adhesion in regulation of asymmetric stem cell division.
Adult stem cells inevitably communicate with their cellular neighbors within the tissues they sustain. Indeed, such communication, particularly with components of the stem cell niche, is essential for...
Clinical Trials
RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant. PURPOSE: This randomized phase III trial is compari...
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune...
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
This study performs HLA matched stem cell transplantation from unrelated donors in adults who require stem cell transplantation but do not have a matched related donor available. The incid...
Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency
The purpose of this study is to determine whether cultivated stem cell transplantation is effective for the treatment of patients wtih corneal stem cell deficiency.
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
Allogeneic stem cell transplantation, the only known curative modality for CML, was abandoned in recent years for a very effective and much less toxic targeted therapy with the tyrosine ki...
Companies
America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of s...
Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers ge...
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected ste...
ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...
Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...
More Information about "America Stem Cell, Inc." on BioPortfolio
We have published hundreds of America Stem Cell, Inc. news stories on BioPortfolio along with dozens of America Stem Cell, Inc. Clinical Trials and PubMed Articles about America Stem Cell, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of America Stem Cell, Inc. Companies in our database. You can also find out about relevant America Stem Cell, Inc. Drugs and Medications on this site too.
